Lee's Pharmaceutical Holdings Limited announced that Dr. Li Xiaoyi chief technical officer of the Company, and ceased to act as an authorised representative of the company with effect from 29 April 2021 as he would like to devote more time to other business commitments. On the same date, Dr. Li has also been re-designated from an executive Director to a non-executive Director of the Company and will serve as a senior adviser to the company. Whilst Dr. Li is no longer responsible for the daily management of the company, he will remain as a non-executive Director and serve as a senior adviser and be available to give advice and share his valuable expertise to the Board for formulating the overall corporate strategies, financial objectives and direction of the Group, provide technical advice on business decisions, establishing goals for management and reviewing their performance for the furtherance of the business success of the Group.